The difference between information and
expert, data-driven actionable intelligence
Welcome to the August 2017 issue of CMC Market Outlook
This monthly e-newsletter provides valuable insights for both buyers and sellers of CMC drug development services. Our coverage will help you identify and understand market trends that will inform your strategic business perspective.
Enjoy the August issue!
CMOs Must Embrace Flexible Manufacturing
by Jim Miller, President, PharmSource
The need for flexibility in manufacturing arrangements and technologies has never been greater. New products are more technically challenging, produced in smaller volumes, and subject to great market uncertainty stemming from competing therapies and reimbursement risk.
Contract development and manufacturing organizations (CDMOs) need to respond in both technical capabilities… read on
CDMOs Buttressed by Resilient Emerging Biopharma Sector
by Saul Richmond, Director of Market Intelligence
Publicly traded emerging biopharmaceutical companies increased their research and development (R&D) expenditure in the second quarter of 2017, reaching almost $3.9 billion, 45% greater than the spending level seen in the second quarter of 2015.
Although the total R&D expenditure of emerging biopharma companies (around $15 billion annually) is a fraction of the $100 billion spent by global bio/pharma companies (25 largest by revenue), it is overwhelmingly outsourced…read on
PharmSource President Jim Miller to Speak at Industry Event
16th Annual Conference and Tabletop Exhibition.
Thursday, September 14
Dose CMOs Stuck in Idle
Save the date!
PBOA First Annual Meeting and Conference
This event is open exclusively to PBOA-member companies!
Get the insider’s view on the regulatory, legislative and market trends driving the biopharmaceutical CDMO industry.
For details on the conference, visit www.pharma-bio.org/conference
PharmSource Strategic Advantage
PharmSource’s STRATEGIC ADVANTAGE service is the industry’s most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. Developed from PharmSource’s expert proprietary research, you won’t find this information in any other resource.
See for yourself how this resource gives you vital tools for understanding the industry.
To request a test-drive today, contact email@example.com / +1-703-383-4903, ext. 112.